Back to results
US 2021/0061785 A1Published application
Imidazolidine compounds
AssigneeEli Lilly and Company
InventorsLian Zhu LIU, Xiaoqing WANG, Michael Robert WILEY
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound of Formula (I) wherein X is selected from the group consisting of (CH2)2— and CH2—CH(CH3)—; Q is selected from the group consisting of C(CH3)2 and Formula (a); or a pharmaceutically acceptable salt thereof; compositions, methods to treat liver disease and NASH.
Claims15
A compound of the formula
- wherein
- X is selected from the group consisting of —(CH2)2— and —CH2—CH(CH3)—;
- Q is selected from the group consisting of —C(CH3)2 and
- R is selected from the group consisting of
- or
- a pharmaceutically acceptable salt thereof.
3 more elements
(canceled)
(canceled)
An intermediate compound of the formula
- wherein
- Q is selected from the group consisting of —C(CH3)2 and
- or
- a pharmaceutically acceptable salt thereof.
1 more element
Dependencies are inferred from the claim text.